The results come as Pfizer tries to regain its footing after the rapid decline of its Covid business. Read this story
The results come as Pfizer tries to regain its footing after the rapid decline of its Covid business. Read this story
More from CNBC | Business Biotechnology Biotech and Pharmaceuticals Pharmaceuticals Health care industry Earnings Breaking news Earnings reports Spin-offs Pfizer Inc Dividends United States business news cnbc Articles US: News Companies Business News Health & Science source:tagname:CNBC US Source Pfizer NYSE:PFE